Semler Scientific, Inc.
NASDAQ:SMLR
24.79 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 68.184 | 56.686 | 53.027 | 38.603 | 32.767 | 21.491 | 12.452 | 7.434 | 7.001 | 3.635 | 2.274 | 1.199 | 0.316 |
| Cost of Revenue
| 6.984 | 4.252 | 6.122 | 3.356 | 3.661 | 2.703 | 2.553 | 1.873 | 2.847 | 0.692 | 0.469 | 0.364 | 0.145 |
| Gross Profit
| 61.2 | 52.434 | 46.905 | 35.247 | 29.106 | 18.788 | 9.899 | 5.561 | 4.154 | 2.943 | 1.805 | 0.835 | 0.171 |
| Gross Profit Ratio
| 0.898 | 0.925 | 0.885 | 0.913 | 0.888 | 0.874 | 0.795 | 0.748 | 0.593 | 0.81 | 0.794 | 0.696 | 0.541 |
| Reseach & Development Expenses
| 5.773 | 4.809 | 3.78 | 2.938 | 2.479 | 2.085 | 1.831 | 0.866 | 1.436 | 1.113 | 0.356 | 0.277 | 0.246 |
| General & Administrative Expenses
| 14.29 | 12.737 | 9.235 | 6.406 | 6.954 | 4.159 | 3.843 | 3.027 | 4.871 | 2.448 | 1.317 | 1.255 | 1.057 |
| Selling & Marketing Expenses
| 18.147 | 17.685 | 14.445 | 9.942 | 8.965 | 7.202 | 5.078 | 3.827 | 6.266 | 3.723 | 2.256 | 1.718 | 0.647 |
| SG&A
| 32.437 | 30.422 | 23.68 | 16.348 | 15.919 | 11.361 | 8.921 | 6.854 | 11.137 | 6.171 | 3.573 | 2.973 | 1.704 |
| Other Expenses
| 0.734 | -0.005 | 0 | 0.443 | -0.009 | -0.004 | -0.014 | -0.395 | -0.082 | 0.001 | -0.001 | -0.203 | -0.031 |
| Operating Expenses
| 38.944 | 35.231 | 27.46 | 19.286 | 18.398 | 13.446 | 10.752 | 7.72 | 12.573 | 7.284 | 3.929 | 3.25 | 1.95 |
| Operating Income
| 22.256 | 17.203 | 19.445 | 15.961 | 10.708 | 5.342 | -0.853 | -2.159 | -8.419 | -4.341 | -2.124 | -2.415 | -1.779 |
| Operating Income Ratio
| 0.326 | 0.303 | 0.367 | 0.413 | 0.327 | 0.249 | -0.069 | -0.29 | -1.203 | -1.194 | -0.934 | -2.014 | -5.63 |
| Total Other Income Expenses Net
| 1.844 | 0.489 | 0.01 | 0.525 | -0.007 | -0.004 | -0.193 | -0.395 | -0.082 | 0.001 | -0.001 | -0.203 | -0.031 |
| Income Before Tax
| 24.1 | 17.692 | 19.455 | 16.486 | 10.701 | 5.04 | -1.51 | -2.554 | -8.501 | -4.515 | -2.233 | -2.738 | -1.874 |
| Income Before Tax Ratio
| 0.353 | 0.312 | 0.367 | 0.427 | 0.327 | 0.235 | -0.121 | -0.344 | -1.214 | -1.242 | -0.982 | -2.284 | -5.93 |
| Income Tax Expense
| 3.517 | 3.367 | 2.233 | 2.479 | -4.383 | 0.026 | -0.109 | -0.452 | -0.315 | -0.02 | 0.107 | 0.003 | 0.002 |
| Net Income
| 20.583 | 14.325 | 17.222 | 14.007 | 15.084 | 5.014 | -1.51 | -2.554 | -8.501 | -4.515 | -2.233 | -2.741 | -1.876 |
| Net Income Ratio
| 0.302 | 0.253 | 0.325 | 0.363 | 0.46 | 0.233 | -0.121 | -0.344 | -1.214 | -1.242 | -0.982 | -2.286 | -5.937 |
| EPS
| 3.06 | 2.13 | 2.56 | 2.13 | 2.34 | 0.66 | -0.28 | -0.5 | -1.72 | -1.1 | -0.47 | -0.98 | -0.67 |
| EPS Diluted
| 2.63 | 1.79 | 2.12 | 1.74 | 1.88 | 0.66 | -0.28 | -0.5 | -1.72 | -1.1 | -0.47 | -0.98 | -0.67 |
| EBITDA
| 22.256 | 17.792 | 19.445 | 15.961 | 10.701 | 5.338 | -0.867 | -2.159 | -8.419 | -4.34 | -1.996 | -2.548 | -1.785 |
| EBITDA Ratio
| 0.326 | 0.314 | 0.367 | 0.413 | 0.327 | 0.248 | -0.07 | -0.29 | -1.203 | -1.194 | -0.878 | -2.125 | -5.649 |